Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model.
Severe developmental and reproductive disorders in wild animals have been linked to high exposure to persistent environmental chemicals with hormonal activity. These adverse effects of environmental estrogens have raised considerable concern and have received increasing attention. Although numerous chemicals with the capacity to interfere with the estrogen receptor (ER) have been identified, information on their molecular mechanism of action and their relative potency is rather limited. For the endometrium, the lack of information is due to the lack of a suitable experimental model. We investigated the functions of phytoestrogens in an endometrial-derived model, RUCA-I rat endometrial adenocarcinoma cells. The cells were cultured on a reconstituted basement membrane to preserve their functional differentiation and estrogen responsiveness. We assessed the relative binding affinity to the estrogen receptor of the selected phytoestrogens coumestrol, genistein, daidzein, and the putative phytoestrogen mangostin compared to estradiol by a competitive Scatchard analysis. The following affinity ranking was measured: 17beta-estradiol >>> coumestrol > genistein > daidzein >>> mangostin. In addition, we investigated the capacity of these compounds to promote the increased production of complement C3, a well-known estradiol-regulated protein of the rat endometrium. All substances tested increased the production of complement C3, although different concentrations were necessary to achieve equivalent levels of induction compared to estradiol. Mechanistically we were able to demonstrate that the increase of complement C3 production was mediated by primarily increasing its steady-state mRNA level. These findings indicate that RUCA-I cells represent a sensitive model system to elucidate relative potencies and functions of environmental estrogens in an endometrium-derived model.
Institut für Molekulare Medizin, Medizinische Universität zu Lübeck, Lübeck, Germany.
A C
AC
Hopert
A
A
Beyer
K
K
Frank
E
E
Strunck
W
W
Wünsche
G
G
Vollmer
D000230:Adenocarcinoma; D000818:Animals; D015932:Complement C3c / Q000235:genetics / Q000378:metabolism; D003375:Coumestrol / Q000378:metabolism / Q000494:pharmacology; D016889:Endometrial Neoplasms; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism*; D004958:Estradiol / Q000378:metabolism / Q000494:pharmacology; D004968:Estrogens, Non-Steroidal / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D019833:Genistein / Q000378:metabolism / Q000494:pharmacology; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D010944:Plants; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D004968:Estrogens, Non-Steroidal; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D004958:Estradiol; D015932:Complement C3c; D019833:Genistein; D003375:Coumestrol